đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to support the registration of the pentavalent...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00343889
Treatments Being Tested
This purpose of the study is to assess the safety and immunogenicity of a G...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-07
Trial ID
NCT01098474
Treatments Being Tested
This study is being done to assess the possibility of the potential integra...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-30
Trial ID
NCT00436007
Treatments Being Tested
In order to reduce the amount of thiomersal in its vaccines, GSK Biological...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-08
Trial ID
NCT01061541
This booster study will assess the immunogenicity, reactogenicity and safet...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06
Trial ID
NCT00332566
Treatments Being Tested
This study will be conducted in three stages. In the DTP booster stage at 1...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-02-01
Trial ID
NCT00291343
Treatments Being Tested
The purposes of this study: * To evaluate the immunogenicity, safety and r...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02-17
Trial ID
NCT00829010
Treatments Being Tested
To assess the immune memory following primary vaccination of DTPw-HBV/Hib v...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-02-10
Trial ID
NCT00169442
The purpose of this study is to assess the immunogenicity in terms of antib...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-07
Trial ID
NCT00814710
Treatments Being Tested
The purpose of this study is to assess the safety and reactogenicity of a b...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-19
Trial ID
NCT00317109
Treatments Being Tested